Results 161 to 170 of about 754,759 (237)

Post-marketing safety profile of dengue vaccines CYD-TDV and TAK-003: analysis of adverse event reports from a European database. [PDF]

open access: yesFront Pharmacol
Gianguzzo VM   +11 more
europepmc   +1 more source

Vaccins contre la dengue, le temps de l’optimisme prudent ? [Dengue vaccines, a time for cautious optimism?]

open access: yes
Vaccine could take a central role in the strategy to reduce the burden of dengue. The development of an effective and safe vaccine must address various immunological challenges. Several vaccines are currently in development.
D'Acremont, V., Filali, A.
core   +1 more source

Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines

open access: yesJournal of Virology, 2014
Roland Züst   +10 more
semanticscholar   +1 more source

Prevention of neuroinfectious-diseases: high impact of vaccination programs - but the potential is not maxed out yet. [PDF]

open access: yesNeurol Res Pract
Klein M   +6 more
europepmc   +1 more source

Willingness to accept the Dengue vaccine among adult Malaysians - An online survey. [PDF]

open access: yesHum Vaccin Immunother
Sreeramareddy CT   +7 more
europepmc   +1 more source

Dengue Virus-Susceptible Animal Models: Research Progress, Core Bottlenecks, and Future Perspectives. [PDF]

open access: yesVaccines (Basel)
Zhang W   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy